Search - tctmd.com

Displaying 1 - 20 of 55

Sort: Relevancy | Date

News Daily News

Patient Age Adds Key Context to D-Dimer in DVT Diagnosis: ADJUST-DVT

Caitlin E. Cox

January 08, 2026

News Daily News

Asundexian Reduces Recurrent Stroke Without Bleeding Risk: OCEANIC-STROKE

Michael O'Riordan

November 24, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2025

Michael O'Riordan

September 30, 2025

News Conference News ESC 2025

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

Caitlin E. Cox

September 01, 2025

News Opinion Editor's Corner ESC 2025

What’s Going to Be Hot at ESC Congress 2025?

Michael O'Riordan

August 25, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2025

Caitlin E. Cox

April 30, 2025

News Conference News ACC 2025

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

Caitlin E. Cox

March 29, 2025

News Daily News

Coverage and Use of Impella and Watchman: A Tale of Four Countries

Michael O'Riordan

March 04, 2025

News Conference News ISC 2025

GFAP Biomarker Assay Can Discern ICH vs Ischemic Stroke

Caitlin E. Cox

February 11, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2024

Shelley Wood

December 03, 2024

News Conference News AHA 2024

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

Shelley Wood

November 14, 2024

News Daily News

New Guidelines for CV Care in Patients Undergoing Noncardiac Surgery

Michael O'Riordan

September 24, 2024

News Daily News

Outpatient Management of Acute PE Remains Underused

Todd Neale

January 29, 2024

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Shelley Wood

January 17, 2024

News Conference News ESC 2023

ONCO DVT Supports 12 Months of Preventive DOACs in Cancer Patients

L.A. McKeown

August 30, 2023

News Opinion Editor's Corner ESC 2023

What’s Going to Be Hot at ESC 2023?

Shelley Wood

August 15, 2023

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

News Daily News

Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE

Todd Neale

October 19, 2022

News Conference News TCT 2022

FLASH: More Data to Support Mechanical Thrombectomy in PE

L.A. McKeown

September 18, 2022

Advertisement

Patient Age Adds Key Context to D-Dimer in DVT Diagnosis: ADJUST-DVT

Asundexian Reduces Recurrent Stroke Without Bleeding Risk: OCEANIC-STROKE

What’s Going to Be Hot at TCT 2025

TCTMD’s Top 10 Most Popular Stories for September 2025

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

What’s Going to Be Hot at ESC Congress 2025?

TCTMD’s Top 10 Most Popular Stories for April 2025

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

Coverage and Use of Impella and Watchman: A Tale of Four Countries

GFAP Biomarker Assay Can Discern ICH vs Ischemic Stroke

TCTMD’s Top 10 Most Popular Stories for November 2024

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

New Guidelines for CV Care in Patients Undergoing Noncardiac Surgery

Outpatient Management of Acute PE Remains Underused

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

ONCO DVT Supports 12 Months of Preventive DOACs in Cancer Patients

What’s Going to Be Hot at ESC 2023?

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE

FLASH: More Data to Support Mechanical Thrombectomy in PE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content